Clinical trial
Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or…
NCT00217711 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00217711 |
|---|---|
| Title | Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery |
| Official title | Oxaliplatin, Irinotecan, and Capecitabine as a Combination Regimen for First-Line Treatment of Advanced or Metastatic Colorectal Cancer |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine, irinotecan hydrochloride, oxaliplatin |
| Enrollment | 23 |
| Start date | May 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Oct 1, 2011 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 5, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: